Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
JCO Oncology Practice|June 17, 2020
Time-Driven Activity-Based Costing Comparison of CT-Guided Versus MR-Guided SBRTNeil R Parikh, Percy P Lee, Steven S Raman, et al.
Advances in Radiation Oncology|December 19, 2022
Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19Ting Martin Ma, Neil R Parikh, Rebecca G Philipson, et al.
Brachytherapy|December 3, 2016
Skin surface brachytherapy: A survey of contemporary practice patternsAnna O Likhacheva, Phillip M Devlin, Shervin M Shirvani, et al.
The Lancet. Oncology|April 25, 2017
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 studyAllen M Chen, Carol Felix, Pin-Chieh Wang, et al.
Advances in Radiation Oncology|December 11, 2020
The Impact of 18F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate CancerNeil R Parikh, Sonny Tsai, Carol Bennett, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2012
Predictors of survival in contemporary practice after initial radiosurgery for brain metastasesAnna Likhacheva, Chelsea C Pinnix, Neil R Parikh, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2020
Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate CancerNeil R Parikh, Eric M Chang, Nicholas G Nickols, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2020
Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate CancerNeil R Parikh, Amar U Kishan, Nathanael Kane, et al.
BMC Cancer|April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic diseaseNeil R Parikh, Claudia Huiza, Jill S Patel, et al.
European Urology Oncology|February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional ImagingTing Martin Ma, Andrei Gafita, David Shabsovich, et al.
Pageof 3